Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 2,612† | 2,421† | 2,295† | 2,190† | 2,138† |
| Net profit | 564 | 486 | 471 | 467 | 419† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Vinod Naik | Executive Director | June 30, 2026 |
| Yasir Y Rawjee | Executive Director | June 30, 2026 |
| Kaushikbhai N Patel | Independent Director | June 30, 2026 |
| Manju Agarwal | Independent Director | June 30, 2026 |
| Savan Godiawala | Independent Director | June 30, 2026 |
| Taruvai Laxminarayanan Easwar | Independent Director | June 30, 2026 |
| Hiren Karsanbhai Patel | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
